Photofrin porfimer sodium: Phase III; marketed for the palliative treatment of obstructive esophageal cancer and endobronchial non-small cell lung cancer

In an Phase III trial in 208 patients followed for a

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE